Skip to main content
SpringerLink
Log in

The safety of supported psilocybin use in Oregon

  • Correspondence
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aday, J. S., Carhart-Harris, R. L. & Woolley, J. D. JAMA Psychiatry 80, 533–534 (2023).

    Article  PubMed  Google Scholar 

  2. Schlag, A. K., Aday, J., Salam, I., Neill, J. C. & Nutt, D. J. J. Psychopharmacol. 36, 258–272 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Carhart-Harris, R. et al. N. Engl. J. Med. 384, 1402–1411 (2021).

    Article  CAS  PubMed  Google Scholar 

  4. Goodwin, G. M. et al. N. Engl. J. Med. 387, 1637–1648 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. Smith, W. R. & Appelbaum, P. S. J. Am. Med. Assoc. 326, 697–698 (2021).

    Article  Google Scholar 

  6. Smith, W. R. & Sisti, D. J. Med. Ethics 47, 807–814 (2021).

    Article  Google Scholar 

  7. Smith, W. R. & Appelbaum, P. S. Neuropharmacology 216, 109165 (2022).

    Article  CAS  PubMed  Google Scholar 

  8. Seybert, C. et al. Nat. Med. 29, 2167–2170 (2023).

    Article  CAS  PubMed  Google Scholar 

  9. Marks, M. Wired https://go.nature.com/47vUH19 (3 January 2024).

  10. Marks, M. Neuropharmacology 226, 109399 (2023).

    Article  CAS  PubMed  Google Scholar 

  11. Yaden, D. B., Potash, J. B. & Griffiths, R. R. JAMA Psychiatry 79, 943–944 (2022).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

W.R.S. is supported by the US National Institute of Mental Health (grant T32MH019112).

Author information

Authors and Affiliations

  1. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    William R. Smith

  2. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA

    William R. Smith

  3. Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Dominic A. Sisti

  4. Department of Psychiatry, Columbia University, Vagelos College of Physicians & Surgeons, New York, NY, USA

    Paul S. Appelbaum

  5. Center for Law, Ethics & Psychiatry, New York State Psychiatric Institute, New York, NY, USA

    Paul S. Appelbaum

Authors
  1. William R. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dominic A. Sisti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul S. Appelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William R. Smith.

Ethics declarations

Competing interests

D.A.S. serves as an ethics advisor to Tactogen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, W.R., Sisti, D.A. & Appelbaum, P.S. The safety of supported psilocybin use in Oregon. Nat Med 30, 17–18 (2024). https://doi.org/10.1038/s41591-023-02727-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02727-4

  • Springer Nature America, Inc.

Search

Navigation